176 related articles for article (PubMed ID: 1429209)
1. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy.
Kihana T; Tsuda H; Teshima S; Okada S; Matsuura S; Hirohashi S
Jpn J Cancer Res; 1992 Sep; 83(9):978-84. PubMed ID: 1429209
[TBL] [Abstract][Full Text] [Related]
2. Detection of p53 gene mutations in fine-needle aspiration biopsied breast cancer specimens: correlations with nuclear p53 accumulations and tumor DNA aneuploidy patterns.
Sato T; Yuyama Y; Watabe K; Okazaki A; Toda K; Okazaki M; Hirata K
Cancer Lett; 1997 May; 115(1):47-55. PubMed ID: 9097978
[TBL] [Abstract][Full Text] [Related]
3. p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor.
Lee JH; Kang YS; Park SY; Kim BG; Lee ED; Lee KH; Park KB; Kavanagh JJ; Wharton JT
Cancer Genet Cytogenet; 1995 Nov; 85(1):43-50. PubMed ID: 8536236
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry.
Kappes S; Milde-Langosch K; Kressin P; Passlack B; Dockhorn-Dworniczak B; Röhlke P; Löning T
Int J Cancer; 1995 Feb; 64(1):52-9. PubMed ID: 7665249
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations and protein accumulation in human ovarian cancer.
Kupryjańczyk J; Thor AD; Beauchamp R; Merritt V; Edgerton SM; Bell DA; Yandell DW
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4961-5. PubMed ID: 8506342
[TBL] [Abstract][Full Text] [Related]
6. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
[TBL] [Abstract][Full Text] [Related]
8. Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?
Yamada R; Maeda N; Oguri H; Adachi Y; Takeuchi T; Furihata M; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):96-100. PubMed ID: 24017961
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
10. Overexpression or mutation of the p53 tumor suppressor gene does not occur in malignant ovarian germ cell tumors.
Liu FS; Ho ES; Chen JT; Shih RT; Yang CH; Shih A
Cancer; 1995 Jul; 76(2):291-5. PubMed ID: 8625105
[TBL] [Abstract][Full Text] [Related]
11. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations.
Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S
Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations and expression in ovarian cancers: correlation with overall survival.
Wen WH; Reles A; Runnebaum IB; Sullivan-Halley J; Bernstein L; Jones LA; Felix JC; Kreienberg R; el-Naggar A; Press MF
Int J Gynecol Pathol; 1999 Jan; 18(1):29-41. PubMed ID: 9891239
[TBL] [Abstract][Full Text] [Related]
13. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
14. p53 gene analysis of ovarian borderline tumors and stage I carcinomas.
Kupryjanczyk J; Bell DA; Dimeo D; Beauchamp R; Thor AD; Yandell DW
Hum Pathol; 1995 Apr; 26(4):387-92. PubMed ID: 7705816
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation in carcinomas arising in ovarian cystic teratomas.
Fujii T; Oguni S; Kikuchi M; Kanai N; Saito K
Pathol Int; 1995 Sep; 45(9):649-54. PubMed ID: 8548037
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.
Yemelyanova A; Vang R; Kshirsagar M; Lu D; Marks MA; Shih IeM; Kurman RJ
Mod Pathol; 2011 Sep; 24(9):1248-53. PubMed ID: 21552211
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma.
Frank TS; Bartos RE; Haefner HK; Roberts JA; Wilson MD; Hubbell GP
Mod Pathol; 1994 Jan; 7(1):3-8. PubMed ID: 7909153
[TBL] [Abstract][Full Text] [Related]
19. p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.
Tamura G; Maesawa C; Suzuki Y; Satodate R; Ishida K; Saito K
Jpn J Cancer Res; 1992 Jun; 83(6):559-62. PubMed ID: 1644659
[TBL] [Abstract][Full Text] [Related]
20. Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.
Bar JK; Harłozińska A; Popiela A; Noga L
Tumour Biol; 2001; 22(2):83-91. PubMed ID: 11125280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
